Beckman_Leader_Board

Telangana to Establish B-Hub for Biotech, Biopharma Sector

The Telangana government said it plans to establish a B-Hub at Genome Valley here to scale up manufacturing activities for biopharma-based Research and Development. The proposed B-Hub, with at an estimated cost of ₹60 crore, would be set up through public private partnership (PPP) in Genome Valley, India’s first organized cluster for life sciences Research & Development and clean manufacturing activities, an official release said. “B-Hub will be a first of its kind initiative in the country, aimed at providing much needed support to the biopharma R&D activities, featuring a scale-up manufacturing facility, along with a turnkey incubator/lab space module at Good Laboratory Practices grade within a built-up area of 40,000 square feet,” it said.

Establishment of an end-to-end biopharma scale-up manufacturing facility would give domestic companies the required impetus viz-a-viz Korea, China and France who have taken lead in biopharma innovation, it added. Companies in early stage clinical development, but lacking the requisite expertise and resources to navigate the complexities associated with business planning, cell line development, process development, technology, and/or regulatory and risk assessment, can leverage B-Hub facility to help break down roadblocks and improve the likelihood of commercial success, the release said. Meanwhile Telangana Minister for IT and Industries KT Rama Rao launched a web portal for the life sciences sector, aimed at creating an interface between the government, industries, research institutions and start-ups, a separate release said. Telangana, which has emerged as the pharma capital of India, has set out an ambitious vision for the sector, through leveraging its existing strengths, to create four lakh jobs at an investment of USD 100 Billion in the next 10 years, it said. – Business Standard

Share this:

Related Post

Stay Updated on Medical Equipment and Devices industry.
Receive our Daily Newsletter.